RSS feed

Publications by Rumi Murata

15 publications found

Original articles

Murai T, Tamura T, Nakabayashi T, Ito H, Manabe Y, Murata R, Niwa M, Shibamoto Y (2019)
Clinical Evaluation of Onrad, A New Low-cost Version of TomoTherapy that Uses Only Static Beams
Kurume Med J, 65 (4), 129-136
DOI 10.2739/kurumemedj.MS654004, PubMed 31723077

Hattori Y, Murai T, Iwata H, Uchiyama K, Mimura M, Kato E, Murata R, Shibamoto Y (2016)
Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experience
Jpn J Radiol, 34 (4), 292-9
DOI 10.1007/s11604-016-0524-8, PubMed 26852128

Murai T, Murata R, Manabe Y, Sugie C, Tamura T, Ito H, Miyoshi Y, Shibamoto Y (2014)
Intensity modulated stereotactic body radiation therapy for single or multiple vertebral metastases with spinal cord compression
Pract Radiat Oncol, 4 (6), e231-7
DOI 10.1016/j.prro.2014.02.005, PubMed 25407874

Murai T, Shibamoto Y, Manabe Y, Murata R, Sugie C, Hayashi A, Ito H, Miyoshi Y (2013)
Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical mode
Radiat Oncol, 8, 68
DOI 10.1186/1748-717X-8-68, PubMed 23517931

Manabe Y, Shibamoto Y, Baba F, Murata R, Yanagi T, Hashizume C, Iwata H, Kosaki K, Miyakawa A, Murai T, Yano M (2011)
Radiotherapy for hilar or mediastinal lymph node metastases after definitive treatment with stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer
Pract Radiat Oncol, 2 (4), e137-e143
DOI 10.1016/j.prro.2011.11.007, PubMed 24674177

Otsuka S, Shibamoto Y, Iwata H, Murata R, Sugie C, Ito M, Ogino H (2011)
Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor
Int J Radiat Oncol Biol Phys, 81 (5), 1538-43
DOI 10.1016/j.ijrobp.2011.05.034, PubMed 22115556

Iwata H, Shibamoto Y, Baba F, Sugie C, Ogino H, Murata R, Yanagi T, Otsuka S, Kosaki K, Murai T, Miyakawa A (2011)
Correlation between the serum KL-6 level and the grade of radiation pneumonitis after stereotactic body radiotherapy for stage I lung cancer or small lung metastasis
Radiother Oncol, 101 (2), 267-70
DOI 10.1016/j.radonc.2011.05.031, PubMed 21640420

Nielsen T, Murata R, Maxwell RJ, Stødkilde-Jørgensen H, Ostergaard L, Ley CD, Kristjansen PE, Horsman MR (2010)
Non-invasive imaging of combretastatin activity in two tumor models: Association with invasive estimates
Acta Oncol, 49 (7), 906-13
DOI 10.3109/0284186X.2010.499135, PubMed 20831477

Baba F, Shibamoto Y, Ogino H, Murata R, Sugie C, Iwata H, Otsuka S, Kosaki K, Nagai A, Murai T, Miyakawa A (2010)
Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size
Radiat Oncol, 5, 81
DOI 10.1186/1748-717X-5-81, PubMed 20849623

Iwata H, Shibamoto Y, Murata R, Tomita N, Ayakawa S, Ogino H, Ito M (2009)
Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study
Int J Radiat Oncol Biol Phys, 75 (2), 482-8
DOI 10.1016/j.ijrobp.2008.12.093, PubMed 19735872

Murata R, Tsujitani M, Horsman MR (2008)
Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole
Radiother Oncol, 87 (3), 331-8
DOI 10.1016/j.radonc.2008.03.002, PubMed 18375007

Nielsen T, Murata R, Maxwell RJ, Stødkilde-Jørgensen H, Ostergaard L, Horsman MR (2007)
Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients
Int J Radiat Oncol Biol Phys, 70 (3), 859-66
DOI 10.1016/j.ijrobp.2007.10.012, PubMed 18164835

Grönroos T, Bentzen L, Marjamäki P, Murata R, Horsman MR, Keiding S, Eskola O, Haaparanta M, Minn H, Solin O (2004)
Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma
Eur J Nucl Med Mol Imaging, 31 (4), 513-20
DOI 10.1007/s00259-003-1404-x, PubMed 14722675

Horsman MR, Murata R (2003)
Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response
Int J Radiat Oncol Biol Phys, 57 (4), 1047-55
DOI 10.1016/s0360-3016(03)00769-7, PubMed 14575836

Horsman MR, Murata R (2002)
Combination of vascular targeting agents with thermal or radiation therapy
Int J Radiat Oncol Biol Phys, 54 (5), 1518-23
DOI 10.1016/s0360-3016(02)03926-3, PubMed 12459380